A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects
NCT07633691
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Adult
Interventions
DRUG:
DA-5223-R
DRUG:
DA-5223-F
DRUG:
DA-5223-M
Sponsor
Dong-A ST Co., Ltd.